Revvity (RVTY) Cash from Operations Growth (5y) (2014 - 2026)
Revvity (RVTY) Cash from Operations Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn |
| 10 | Revvity | 12.76 Bn | 11.90 Bn | 387.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | -24.62% |
| Dec 28, 2025 | -8.60% |
| Sep 28, 2025 | -8.11% |
| Jun 29, 2025 | -0.63% |
| Mar 30, 2025 | 16.37% |
| Dec 29, 2024 | -4.14% |
| Sep 29, 2024 | 2.65% |
| Jun 30, 2024 | 31.22% |
| Mar 31, 2024 | 97.76% |
| Dec 31, 2023 | -27.25% |
| Oct 1, 2023 | -19.92% |
| Jul 2, 2023 | -19.97% |
| Apr 2, 2023 | 44.77% |
| Jan 1, 2023 | -34.75% |
| Apr 3, 2022 | 43.42% |
| Apr 4, 2021 | 78.29% |
| Oct 4, 2020 | 28.35% |
| Jul 5, 2020 | 16.90% |
| Apr 5, 2020 | 9.78% |
| Dec 29, 2019 | 17.54% |